Page last updated: 2024-12-05

delta-valerolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Delta-valerolactone (δ-valerolactone) is a cyclic lactone with the molecular formula C5H8O2. It is a colorless liquid with a sweet odor. It is found naturally in some fruits and vegetables and is used as a flavoring agent and solvent. It is also a versatile intermediate in the synthesis of pharmaceuticals and other fine chemicals. Research has focused on its synthesis, including methods like ring-opening metathesis polymerization and enzymatic reactions. Its effects are being studied for potential applications in polymer chemistry, as a precursor to polyesters, and as a biofuel. The importance of delta-valerolactone stems from its biocompatibility, its ability to form polymers, and its potential as a renewable resource.'

Cross-References

ID SourceID
PubMed CID10953
CHEMBL ID452383
CHEBI ID16545
SCHEMBL ID37722
MeSH IDM0148266

Synonyms (78)

Synonym
nsc 65442
wln: t6ovtj
tetrahydro-2-pyranone
nsc6247
valeric acid, .delta.-lactone
2h-pyran-2-one, tetrahydro-
.delta.-valerolactone
pentanoic acid, .delta.-lactone
.delta.-valeryllactone
nsc-6247
CHEBI:16545 ,
valerolactone
nsc65442
nsc-65442
26354-94-9
inchi=1/c5h8o2/c6-5-3-1-2-4-7-5/h1-4h
tetrahydro-2h-pyran-2-one
542-28-9
5-valerolactone ,
C02240
delta-valerolactone
delta-valerolactone, technical grade
oxan-2-one
V0039
delta-valerolactotie
CHEMBL452383 ,
tox21_302166
cas-542-28-9
dtxcid4024438
dtxsid6044438 ,
NCGC00255756-01
tetrahydro-pyran-2-one
bdbm50360797
penta-1,5-lactone
14v1x9149l ,
valeric acid, delta-hydroxy-, delta-lactone
einecs 208-807-1
nsc 6247
unii-14v1x9149l
pentanoic acid, 5-hydroxy-, delta-lactone
delta-valeryllactone
ec 208-807-1
ai3-25024
FT-0624505
AKOS009158729
delta-valerolactone [inci]
S3099
tetrahydro-4h-pyranone
delta valerolactone
tetrahydropyran-2-one
SCHEMBL37722
W-105654
.delta.-pentalactone
5-hydroxypentanoic acid .delta.-lactone
pentan-5-olide
pentanoic acid, 5-hydroxy-, .delta.-lactone
5-pentanolide
1-oxacyclohexan-2-one
cyclopentanolide
valeric acid, .delta.-hydroxy-, .delta.-lactone
STR08736
42932-61-6
mfcd00006645
delta-valerolactone (may contain polymer)
CS-W013713
HY-W012997
(difluoro-trimethylsilanyl-methyl)-phosphonicacid
Q903610
SY018264
d-valerolactone
delta-valerolactone-3,3,4,4-d4
o-valeryllactone
o-valerolactone
2-oxotetrahydropyran
tetrahydro-2h-2-pyranone
EN300-43042
delta -valerolactone
Z432085120

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Physicochemical properties, biodegradability, and biocompatibility of the polymers, and evaluations in vitro and in vivo of specific dosage forms using the polymers, are included."( Poly(hydroxy acids) in drug delivery.
Juni, K; Nakano, M, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
delta-lactoneA lactone having a six-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 1Homo sapiens (human)Ki9.60000.00001.372610.0000AID639299
Carbonic anhydrase 2Homo sapiens (human)Ki100.00000.00000.72369.9200AID639300
Carbonic anhydrase 9Homo sapiens (human)Ki3.66000.00010.78749.9000AID639301
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID639299Inhibition of human CA1 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
AID342465Activity at human recombinant PON1 assessed as hydrolysis of lactone ring at 1 mM by Ellman's method2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity.
AID639301Inhibition of human CA9 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
AID639300Inhibition of human CA2 pre-incubated for 15 mins to 24 hrs measured after 6 hrs by phenol red-based stopped-flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.50)18.7374
1990's1 (2.50)18.2507
2000's14 (35.00)29.6817
2010's21 (52.50)24.3611
2020's3 (7.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.01 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index50.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (97.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]